Henry Schein, Inc. (NASDAQ:HSIC) Shares Purchased by Ossiam

Ossiam raised its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 20.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 22,619 shares of the company's stock after purchasing an additional 3,883 shares during the quarter. Ossiam's holdings in Henry Schein were worth $1,565,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Versant Capital Management Inc increased its stake in Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after buying an additional 335 shares during the period. Venturi Wealth Management LLC increased its stake in shares of Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after acquiring an additional 569 shares during the period. Quent Capital LLC raised its holdings in Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after purchasing an additional 323 shares in the last quarter. Smartleaf Asset Management LLC lifted its position in Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after purchasing an additional 143 shares during the period. Finally, City State Bank acquired a new position in Henry Schein during the 4th quarter worth approximately $55,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the stock. UBS Group lowered their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. Barrington Research reiterated an "outperform" rating and set a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Wells Fargo & Company assumed coverage on Henry Schein in a research note on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price objective for the company. Jefferies Financial Group upped their target price on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. Finally, Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and boosted their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $81.10.

Insider Buying and Selling

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now directly owns 24,805 shares of the company's stock, valued at $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company's stock.

Henry Schein Trading Down 1.6 %

HSIC traded down $1.06 during trading on Friday, hitting $65.17. The company's stock had a trading volume of 736,944 shares, compared to its average volume of 1,615,735. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The stock has a market cap of $7.98 billion, a PE ratio of 26.82, a PEG ratio of 2.13 and a beta of 0.84. The firm's 50 day moving average price is $69.46 and its 200-day moving average price is $71.81. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business's revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.66 earnings per share. On average, analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.